Antiparasitics such as ivermectin, mebendazole, and fenbendazole are often attacked the moment they come up in cancer care.

Dr. William Makis published three stage 4 cases after fenbendazole was added.

The reported results were very good, with follow-up lasting up to three years.

The paper passed peer review and was published. But it was then pulled over a procedural complaint, with no serious follow-up on the cases themselves.

Join 👉 https://t.me/RogerHodkinson